<PAGE> 1
FORM 8-A
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------------
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
KING PHARMACEUTICALS, INC.
- --------------------------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
Tennessee 54-168493
- --------------------------------------------------------------------------------
(State of incorporation or organization) (I.R.S. Employer
Identification No.)
501 Fifth Street, Bristol, Tennessee 37620
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
If this form relates to the If this form relates to the
registration of a class of registration of a class of
securities pursuant to Section securities pursuant to Section
12(b) of the Exchange Act and is 12(g) of the Exchange Act and is
effective pursuant to General effective pursuant to General
Instruction A.(c), please check the Instruction A.(d), please check the
following box. [x] following box. [ ]
Securities Act registration statement file number to which this
form relates: _______________
(If applicable)
<PAGE> 2
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange on which
To be so registered each class is to be registered
------------------- ------------------------------
Common Stock, no par value New York Stock Exchange
Preferred Stock Purchase Rights New York Stock Exchange
Securities to be registered pursuant to Section 12(g) of the Act:
Not Applicable
------------------
(Title of Class)
- 2 -
<PAGE> 3
ITEM 1. DESCRIPTION OF THE REGISTRANT'S SECURITIES TO BE REGISTERED.
Common Stock, no par value, and associated Preferred Stock
Purchase Rights
The information included under the caption "Description of Capital
Stock" in the Prospectus Supplement dated April 19, 2000 (To Prospectus Dated
April 19, 2000) contained in the Registration Statement on Form S-3 (File No.
333-95181) of King Pharmaceuticals, Inc. filed with the Securities and Exchange
Commission on January 21, 2000 is hereby incorporated by reference. In addition,
the description of the Common Stock, no par value per share, included under the
caption "Description of Capital Stock" in any Prospectus Supplement relating to
such Registration Statement filed with the Securities and Exchange Commission
pursuant to any subsequent amendment of such Registration Statement or pursuant
to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed to
be incorporated herein by reference.
ITEM 2. EXHIBITS
(a) 1. Second Amended and Restated Charter of King Pharmaceuticals,
Inc. (Incorporated by reference to Registrant's Registration
Statement on Form S-1 filed October 24, 1997).
2. Amended and Restated Bylaws of King Pharmaceuticals, Inc.
(Incorporated by reference to Registrant's Registration Statement
on Form S-1 filed October 24, 1997).
3. Specimen Stock Certificate (Incorporated by reference to
Registrant's Registration Statement on Form S-1 filed October 24,
1997).
4. Form of Rights Agreement by and between King Pharmaceuticals,
Inc. and Union Planters National Bank (Incorporated by reference
to Registrant's Registration Statement on Form S-1 filed
October 24, 1997).
(b) All exhibits required by Instruction II to Item 2 will be
supplied to the New York Stock Exchange.
- 3 -
<PAGE> 4
SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the Registrant has duly caused this Registration Statement to be signed
on its behalf by the undersigned, thereunto duly authorized.
KING PHARMACEUTICALS, INC.
Date: May 12, 2000 By: /s/ John M. Gregory
--------------------------------------
John M. Gregory, Chairman of the Board
and Chief Executive Officer
- 4 -
